• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制患者的黑热病。关于一例由皮肤病变揭示的病例

[Kala-azar in immunosuppressed patients. Apropos of a case disclosed by skin lesions].

作者信息

Frances C, Merle Beral H, Franceschini P, Lessana-Leibowitch M, Escande J P

出版信息

Presse Med. 1984 Nov 10;13(40):2433-6.

PMID:6239222
Abstract

Kala-azar was revealed by skin lesions in a patient treated for recurrent Hodgkin's disease. These lesions, extremely discreet, consisted of papules on the forehead and in the peribuccal area. Histological examinations initially showed nodular infiltration of the dermis with very few Leishman-Donovan bodies; subsequently, foamy, Virchow-type histiocytes appeared, and Leishman-Donovan bodies became numerous. This clinical and histological similarity with leprosy has already been noted for post-kala-azar dermal leishmaniasis which is frequent in India and in Ethiopia. Skin lesions in kala-azar appear to be exceptional since they were not observed in the 7 cases of kala-azar in immunodepressed patients previously published. The fact that they are discreet may account for their apparent rareness. Easily accessible, they make it possible to diagnose visceral leishmaniasis--an often difficult diagnosis in these patients owing to the underlying disease. Immunodepression has little influence on the clinical and biological manifestations of kala-azar, but reserves must be made concerning the usual criteria for cure.

摘要

在一名接受复发性霍奇金病治疗的患者中,通过皮肤病变确诊了黑热病。这些病变极为隐匿,表现为前额和颊周区域的丘疹。组织学检查最初显示真皮有结节状浸润,利什曼-多诺万小体极少;随后,出现了泡沫状的维尔肖型组织细胞,利什曼-多诺万小体数量增多。与麻风病的这种临床和组织学相似性在印度和埃塞俄比亚常见的黑热病后皮肤利什曼病中已有记载。黑热病中的皮肤病变似乎很罕见,因为在先前发表的7例免疫抑制患者的黑热病病例中未观察到。它们隐匿的特点可能解释了其明显的罕见性。由于易于获取,这些病变使得内脏利什曼病的诊断成为可能——鉴于基础疾病,对这些患者来说这往往是一项困难的诊断。免疫抑制对黑热病的临床和生物学表现影响不大,但在通常的治愈标准方面必须有所保留。

相似文献

1
[Kala-azar in immunosuppressed patients. Apropos of a case disclosed by skin lesions].免疫抑制患者的黑热病。关于一例由皮肤病变揭示的病例
Presse Med. 1984 Nov 10;13(40):2433-6.
2
Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.黑热病后皮肤利什曼病的组织病理学特征:88例患者系列研究
Indian J Dermatol Venereol Leprol. 2015 Jan-Feb;81(1):29-34. doi: 10.4103/0378-6323.148562.
3
Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.在印度北部一家三级医疗中心对一种用于诊断黑热病和黑热病后皮肤利什曼病的快速免疫层析检测进行评估。
Indian J Med Res. 2005 Dec;122(6):485-90.
4
Post-kala-azar dermal leishmaniasis.黑热病后皮肤利什曼病
Br J Dermatol. 1977 Sep;97(3):307-11. doi: 10.1111/j.1365-2133.1977.tb15188.x.
5
Imported kala-azar: a case report.
Zhonghua Yi Xue Za Zhi (Taipei). 1992 Nov;50(5):411-4.
6
Post-kala-azar dermal leishmaniasis in Nepal.尼泊尔的黑热病后皮肤利什曼病
Int J Dermatol. 2001 Mar;40(3):179-84. doi: 10.1046/j.1365-4362.2001.01198.x.
7
Nodular post-kala-azar dermal leishmaniasis: a distinct histopathological entity.结节型黑热病后皮肤利什曼病:一种独特的组织病理学实体。
J Cutan Pathol. 1998 Feb;25(2):95-9. doi: 10.1111/j.1600-0560.1998.tb01696.x.
8
Post-kala-azar dermal leishmaniasis.黑热病后皮肤利什曼病
Eur J Dermatol. 1998 Jun;8(4):277-9.
9
Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.孟加拉国黑热病流行地区黑热病后皮肤利什曼病的皮肤病变谱
Mymensingh Med J. 2012 Jul;21(3):529-32.
10
Fine-needle sampling provides appreciable diagnostic yield in lesions of post kala azar dermal leishmaniasis: analysis of four cases from North Eastern India.细针采样在黑热病后皮肤利什曼病病变中具有可观的诊断价值:来自印度东北部的4例病例分析
Diagn Cytopathol. 2014 Jun;42(6):525-9. doi: 10.1002/dc.22953. Epub 2013 Feb 26.

引用本文的文献

1
Rare association of Visceral leishmaniasis with Hodgkin's disease: A case report.内脏利什曼病合并霍奇金病的罕见关联:一例报告。
Infect Agent Cancer. 2011 Oct 20;6(1):17. doi: 10.1186/1750-9378-6-17.